(78 days)
Not Found
Yes
The device description explicitly mentions the use of "multivariate pattern recognition methods" for tissue segmentation and classification, which is a common technique used in machine learning.
No
The device is a Computer Aided Detection (CAD) system used for analyzing MRI studies and providing information for screening and diagnosis; it does not directly treat or prevent a disease or condition.
Yes
The device aids in analyzing MRI studies, segments and labels tissue, performs image processing, and provides measurements that may be useful in screening and diagnosis, especially "when interpreted by a skilled physician". This fits the definition of a diagnostic device as it provides information used to identify or characterize a disease or condition.
No
The device description explicitly states that the CADstream system consists of proprietary software installed on an "off-the-shelf personal computer and a monitor configured as a CADstream display station," and lists a "PC Server" and "Archive System" as key components. While the core functionality is software-based, the system includes dedicated hardware components.
Based on the provided text, the CADstream™ device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze biological samples: IVDs are designed to examine specimens taken from the human body, such as blood, urine, tissue, etc., to provide information about a person's health.
- CADstream analyzes medical images: The CADstream system analyzes Magnetic Resonance Imaging (MRI) studies, which are medical images of the body, not biological samples.
- The intended use is image processing and analysis: The description clearly states that CADstream is a Computer Aided Detection (CAD) system intended for analyzing MRI studies, registering images, segmenting tissues, and performing post-processing.
- The device description focuses on software and hardware for image analysis: The components listed are a PC server, software for analysis and viewing, and an archive system, all related to processing and managing image data.
Therefore, while CADstream is a medical device used in diagnosis, it falls under the category of medical imaging software and not In Vitro Diagnostics.
No
The letter does not explicitly state that the FDA has reviewed and approved or cleared a Predetermined Change Control Plan (PCCP) for this specific device. The section "Control Plan Authorized (PCCP) and relevant text" is marked as "Not Found."
Intended Use / Indications for Use
CADstream™ is a Computer Aided Detection (CAD) system intended for use in analyzing magnetic resonance imaging (MRI) studies. CADstream automatically registers serial patient image acquisitions (in 2D or 3D) to minimize the impact of patient motion, segments and labels tissue types based on enhancement characteristics (parametric image maps, referred to as angiogenesis maps), and performs other userdefined post-processing functions (image subtractions, multiplanar reformats, maximum intensity projections).
CADstream also can be used to provide accurate and reproducible measurements of the longest diameters and volume of segmented tissues, including automated determination of volumes of interest (VOI), calculation of the longest diameter in X, Y and Z dimensions, the areas of VOI, the volume measurements of VOI (reported in cc), and 3D renderings of VOI.
The system includes an optional remote image viewer (CADalyst™), optimized for viewing breast MR studies processed by CADstream.
CADstream™ includes software to support the use of breast interventional coils and MR stereotactic localization devices to perform breast interventional procedures (SureLoc™). Using information from MR images regarding the coordinates of a user-specified region of interest, and fiducial coordinates, the software provides an automatic calculation of the location and depth of the targeted region of interest, such as a lesion or suspected lesion.
When interpreted by a skilled physician, this device provides information that may be useful in screening and diagnosis. Patient management decisions should not be made based solely on the results of CADstream analysis.
Product codes (comma separated list FDA assigned to the subject device)
90 LNH
Device Description
The CADstream device relies on the assumption that pixels having similar MR signal intensities represent similar tissues. The CADstream software simultaneously analyzes the pixel signal intensities from multiple MR sequences and applies multivariate pattern recognition methods to perform tissue segmentation and classification. CADstream is designed to analyze dynamic breast MRI studies.
The CADstream system consists of proprietary software developed by Confirma installed on an off-the-shelf personal computer and a monitor configured as a CADstream display station.
The CADstream System consists of the following key components:
- . A PC Server: a desk-side or rack mount PC capable of running the Server software, Client User Interface software, and Study Viewer software
- . Server software: performs CADstream analysis and processing
- Client User Interface software: an administrative web page hosted on the Server .
- Study Viewer software (CADalyst): an optional Image Viewer component. . optimized for viewing breast MR studies processed by CADstream
- Archive System: a PC with CD burner and printer .
In all cases, images are acquired and pushed to the CADstream system from the MR scanner. CADstream is configured to automatically process the images and create additional series. In this configuration, CADstream forwards the processed and original images to the existing softcopy reading station.
Mentions image processing
Yes
Mentions AI, DNN, or ML
No
Input Imaging Modality
magnetic resonance imaging (MRI)
Anatomical Site
Breast
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Skilled physician.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance testing of the features described in the user manual has been successfully completed utilizing clinical datasets. Software testing has been completed, through verification and validating testing, and the requirements for these features have been met. The potential hazards have been studied and controlled as part of the product development process, risk management activities, test and design considerations, and planned verification and validation testing.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K031779, K020289, K000832, K010773
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1000 Magnetic resonance diagnostic device.
(a)
Identification. A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).(b)
Classification. Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
1020
JUL - 7 2004
510(k) Summary of Safety and Effectiveness
This 510(k) summary of safety and effectiveness information is submitted in accordance with the requirements of 21 CFR Part 807.87 (h)
1. Identification of Submitter:
| Name: | Patricia A. Milbank |
|---|---|
| Title: | Regulatory Consultant |
| Address: | Confirma |
| 821 Kirkland Avenue | |
| Kirkland, WA 98033 | |
| Phone: | 425-894-9733 |
| Fax: | 425-576-9295 |
| Date Prepared: | April 15, 2004 |
2. Identification of Product:
| Device name | CADstream™ Version 3.1 |
|---|---|
| Classification: | 21 CFR Section 892.1000 |
| Manufacturer | Confirma, Inc. |
| Distributor | 821 Kirkland Avenue |
| Kirkland, WA 98033 |
3. Marketed Devices
The Confirma product is substantially equivalent to the devices listed below:
| Model: | CADstream™ Version 2.0 |
|---|---|
| Manufacturer: | Confirma, Inc. |
| 510 (k) Number: | K031779 |
| Model: | MICS Intervention Aid and MICS Intervention Aid PC- |
| software package used to support stereotactic localization | |
| device | |
| Manufacturer: | Machnet BV |
| 510 (k) Number: | K020289 |
| Model: | Software to support Stereotactic Localization Device (SLD) |
| included in Phillips GYROSCAN NT system | |
| Manufacturer: | Phillips Medical Systems |
| 510 (k) Number: | K000832 |
| Model: | Software to support MR Breast Biopsy Device included in |
| Siemens MAGNETOM system | |
| Manufacturer: | Siemens Medical Systems |
| 510 (k) Number: | K010773 |
1
4. Device Description:
The CADstream device relies on the assumption that pixels having similar MR signal intensities represent similar tissues. The CADstream software simultaneously analyzes the pixel signal intensities from multiple MR sequences and applies multivariate pattern recognition methods to perform tissue segmentation and classification. CADstream is designed to analyze dynamic breast MRI studies.
The CADstream system consists of proprietary software developed by Confirma installed on an off-the-shelf personal computer and a monitor configured as a CADstream display station.
The CADstream System consists of the following key components:
- . A PC Server: a desk-side or rack mount PC capable of running the Server software, Client User Interface software, and Study Viewer software
- . Server software: performs CADstream analysis and processing
- Client User Interface software: an administrative web page hosted on the Server .
- Study Viewer software (CADalyst): an optional Image Viewer component. . optimized for viewing breast MR studies processed by CADstream
- Archive System: a PC with CD burner and printer .
In all cases, images are acquired and pushed to the CADstream system from the MR scanner. CADstream is configured to automatically process the images and create additional series. In this configuration, CADstream forwards the processed and original images to the existing softcopy reading station.
5. Indications for Use
CADstream™ is a Computer Aided Detection (CAD) system intended for use in analyzing magnetic resonance imaging (MRI) studies. CADstream automatically registers serial patient image acquisitions (in 2D or 3D) to minimize the impact of patient motion, segments and labels tissue types based on enhancement characteristics (parametric image maps, referred to as angiogenesis maps), and performs other userdefined post-processing fimage subtractions, multiplanar reformats, maximum intensity projections).
CADstream also can be used to provide accurate and reproducible measurements of the longest diameters and volume of segmented tissues. including automated determination of volumes of interest (VOI), calculation of the longest diameter in X, Y and Z dimensions, the areas of VOI, the volume measurements of VOI (reported in cc), and 3D renderings of VOI.
The system includes an optional remote image viewer (CADalyst™), optimized for viewing breast MR studies processed by CADstream.
2
CADstream™ includes software to support the use of breast interventional coils and MR stereotactic localization devices to perform breast interventional procedures (SureLoc™). Using information from MR images regarding the coordinates of a user-specified region of interest, and fiducial coordinates, the software provides an automatic calculation of the location and depth of the targeted region of interest, such as a lesion or suspected lesion.
When interpreted by a skilled physician, this device provides information that may be useful in screening and diagnosis. Patient management decisions should not be made based solely on the results of CADstream analysis.
6. Comparison with Predicate Devices
CADstream Version 3.1 is substantially equivalent to the following software devices approved for use to support the use of breast biopsy coils and stereotactic localization devices by providing an automatic calculation of the location and depth of regions of interest, such as lesions or suspected lesions:
| Model: | CADstream™ Version 2.0 |
|---|---|
| Manufacturer: | Confirma, Inc. |
| 510 (k) Number: | K031779 |
| Model: | MICS Intervention Aid and MICS Intervention Aid PC- software package used to support stereotactic localization device |
| Manufacturer: | Machnet BV |
| 510 (k) Number: | K020289 |
| Model: | Software to support Stereotactic Localization Device (SLD) included in Phillips GYROSCAN NT system |
| Manufacturer: | Phillips Medical Systems |
| 510 (k) Number: | K000832 |
| Model: | Software to support MR Breast Biopsy Device included in Siemens MAGNETOM system |
| Manufacturer: | Siemens Medical Systems |
| 510 (k) Number: | K010773 |
7. Software Development
The CADstream device has been designed, developed, tested and validated according to written procedures. These procedures identify functions within the organization responsible for developing and approving product specifications, coding and testing, verification and validation testing, and technical support.
3
8. Performance
The product has successfully completed the required integration and verification testing. Assessment of the product has been performed throughout the design development process in accordance with internal procedures and IEC 601-1-4.
9. Clinical Evaluation
Performance testing of the features described in the user manual has been successfully completed utilizing clinical datasets. Software testing has been completed, through verification and validating testing, and the requirements for these features have been met. The potential hazards have been studied and controlled as part of the product development process, risk management activities, test and design considerations, and planned verification and validation testing.
4
Image /page/4/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the perimeter. Inside the circle is an abstract image of an eagle, with three stylized lines representing the bird's body and wings.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL - 7 2004
Ms. Patricia A. Milbank Regulatory Consultant Confirma, Inc. 821 Kirkland Avenue, Suite 100 KIRKLAND WA 98033
Re: K041020
Trade/Device Name: CADstream™ Version 3.1 Regulation Number: 21 CFR 892.1000 Regulation Name: Magnetic resonance diagnostic device Regulatory Class: II
Product Code: 90 LNH Dated: April 19, 2004 Received: April 20, 2004
Dear Ms. Milbank:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
5
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of the letter:
| 8xx.1xxx | (301) 594-4591 |
|---|---|
| 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 |
| 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 |
| 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 |
| Other | (301) 594-4692 |
Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Nancy C. Bugden
Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Indication(s) for Use Statement 5
Ko41020 To be assigned by FDA 510(k) Number:
CADstream™ Version 3.1 Device Name:
Indications for Use:
CADstream™ is a Computer Aided Detection (CAD) system intended for use in analyzing magnetic resonance imaging (MRI) studies. CADstream automatically anaighing wisg rrial patient image acquisitions (in 2D or 3D) to minimize the impact of patient motion, segments and labels tissue types based on enhancement characteristics (parametric image maps, referred to as angiogenesis maps), and performs other userdefined post-processing functions (image subtractions, multiplanar reformats. maximum intensity projections).
CADstream also can be used to provide accurate and reproducible mcasurements of the longest diameters and volume of segmented tissues, including automated determination of volumes of interest (VOI), calculation of the longest diameter in X, Y and Z dimensions. the areas of VOI, the volume measurements of VOI (reported in cc), and 3D renderings of VOI.
The system includes an optional remote image viewer (CADalyst™), optimized for viewing breast MR studies processed by CADstream.
CADstream™ includes software to support the use of breast interventional coils and MR stcreotactic localization devices to perform breast interventional procedures (SureLoc™). Using information from MR images regarding the coordinates of a user-specified region of interest, and fiducial coordinates, the software provides an automatic calculation of the location and depth of the targeted region of interest. such as a lesion or suspected lesion.
When interpreted by a skilled physician, this device provides information that may be useful in screening and diagnosis. Patient management decisions should not be made based solely on the results of CADstream analysis.
Prescription Use V ___________________________________________________________________________________________________________________________________________________________ Over-The-Counter Use __ AND/OR l reseription USC —
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
57:461 Nimbar
Confirma. Inc. Original 510(k)
| Confidential | |
|---|---|
| (Division Sign-Off) | |
| Division of Reproductive, Abdominal, and Radiological Devices | 000011 |
| K041020 |